Luis M. Vilá to Disease Progression
This is a "connection" page, showing publications Luis M. Vilá has written about Disease Progression.
Connection Strength
1.235
-
Nieves-Plaza M, Ortiz AP, Col?n M, Molina MJ, Castro-Santana LE, Rodr?guez VE, Mayor AM, Vil? LM. Outcome and predictors of kidney disease progression in Puerto Ricans with systemic lupus erythematosus initially presenting with mild renal involvement. J Clin Rheumatol. 2011 Jun; 17(4):179-84.
Score: 0.290
-
Gonz?lez-Mel?ndez A, B?ez-Negr?n L, R?os-Rivera R, Franco-O'Connell AS, Nieves-Plaza M, Vil? LM. Short- and mid-term outcomes in systemic lupus erythematosus patients presenting with disease exacerbation after SARS-CoV-2 mRNA vaccination: A cohort study from Puerto Rico. Lupus. 2023 Apr; 32(4):571-579.
Score: 0.162
-
V?zquez-Otero I, Medina-Cintr?n N, Arroyo-?vila M, Gonz?lez-Sep?lveda L, Vil? LM. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus. Lupus Sci Med. 2020 05; 7(1).
Score: 0.134
-
Alarc?n GS, Ugarte-Gil MF, Pons-Estel G, Vil? LM, Reveille JD, McGwin G. Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort. Lupus. 2019 Mar; 28(3):423-426.
Score: 0.123
-
Santiago-Casas Y, Vil? LM, McGwin G, Cantor RS, Petri M, Ramsey-Goldman R, Reveille JD, Kimberly RP, Alarc?n GS, Brown EE. Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort. Arthritis Care Res (Hoboken). 2012 May; 64(5):704-12.
Score: 0.077
-
Zhang J, Gonz?lez LA, Roseman JM, Vil? LM, Reveille JD, Al?rcon GS. Predictors of the rate of change in disease activity over time in LUMINA, a multiethnic US cohort of patients with systemic lupus erythematosus: LUMINA LXX. Lupus. 2010 May; 19(6):727-33.
Score: 0.066
-
Gonz?lez LA, Pons-Estel GJ, Zhang J, Vil? LM, Reveille JD, Alarc?n GS. Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohort. Lupus. 2009 Aug; 18(9):822-30.
Score: 0.064
-
Pons-Estel GJ, Alarc?n GS, McGwin G, Danila MI, Zhang J, Bastian HM, Reveille JD, Vil? LM. Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort. Arthritis Rheum. 2009 Jun 15; 61(6):830-9.
Score: 0.063
-
Vil? LM, Alarc?n GS, McGwin G, Bastian HM, Fessler BJ, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Arthritis Rheum. 2006 Oct 15; 55(5):799-806.
Score: 0.053
-
Vil? LM, Mayor AM, Valent?n AH, Garc?a-Soberal M, Vil? S. Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Lupus. 2000; 9(2):110-5.
Score: 0.033
-
Burgos PI, McGwin G, Reveille JD, Vil? LM, Brown EE, Alarcon GS. Is familial lupus different from sporadic lupus? Data from LUMINA (LXXIII), a multiethnic US cohort. Lupus. 2010 Oct; 19(11):1331-6.
Score: 0.017
-
Pons-Estel GJ, Alarc?n GS, Gonz?lez LA, Zhang J, Vil? LM, Reveille JD, McGwin G. Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort. Arthritis Care Res (Hoboken). 2010 Mar; 62(3):393-400.
Score: 0.017
-
Sanchez ML, McGwin G, Dur?n S, Fern?ndez M, Reveille JD, Vil? LM, Alarc?n GS. Factors predictive of overall health over the course of the disease in patients with systemic lupus erythematosus from the LUMINA cohort (LXII): use of the SF-6D. Clin Exp Rheumatol. 2009 Jan-Feb; 27(1):67-71.
Score: 0.015
-
Dur?n-Barrag?n S, McGwin G, Vil? LM, Reveille JD, Alarc?n GS. Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort. Rheumatology (Oxford). 2008 Jul; 47(7):1093-6.
Score: 0.015
-
Andrade RM, Alarc?n GS, Gonz?lez LA, Fern?ndez M, Apte M, Vil? LM, McGwin G, Reveille JD. Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV). Ann Rheum Dis. 2008 Jun; 67(6):829-34.
Score: 0.014
-
Fern?ndez M, Alarc?n GS, McGwin G, Sanchez ML, Apte M, Vil? LM, Reveille JD. Using the Short Form 6D, as an overall measure of health, to predict damage accrual and mortality in patients with systemic lupus erythematosus: XLVII, results from a multiethnic US cohort. Arthritis Rheum. 2007 Aug 15; 57(6):986-92.
Score: 0.014
-
Fern?ndez M, Alarc?n GS, Apte M, Andrade RM, Vil? LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort: XLIII. The significance of thrombocytopenia as a prognostic factor. Arthritis Rheum. 2007 Feb; 56(2):614-21.
Score: 0.013
-
Andrade RM, Alarc?n GS, Fern?ndez M, Apte M, Vil? LM, Reveille JD. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort. Arthritis Rheum. 2007 Feb; 56(2):622-30.
Score: 0.013
-
Bastian HM, Alarc?n GS, Roseman JM, McGwin G, Vil? LM, Fessler BJ, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria. Rheumatology (Oxford). 2007 Apr; 46(4):683-9.
Score: 0.013
-
Alarc?n GS, McGwin G, Petri M, Ramsey-Goldman R, Fessler BJ, Vil? LM, Edberg JC, Reveille JD, Kimberly RP. Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort. PLoS Med. 2006 Oct; 3(10):e396.
Score: 0.013
-
Bertoli AM, Alarc?n GS, McGwin G, Fern?ndez M, Bastian HM, Fessler BJ, Vil? LM, Reveille JD. Systemic lupus erythematosus in a multiethnic U.S. cohort (LUMINA) XXVII: factors predictive of a decline to low levels of disease activity. Lupus. 2006; 15(1):13-8.
Score: 0.012
-
Bertoli AM, Fern?ndez M, Calvo-Al?n J, Vil? LM, Sanchez ML, Reveille JD, Alarc?n GS. Systemic lupus erythematosus in a multiethnic U.S. cohort (LUMINA) XXXI: factors associated with patients being lost to follow-up. Lupus. 2006; 15(1):19-25.
Score: 0.012